Serum IL-6, TNF&alpha; and CRP levels in Greek colorectal cancer patients: Prognostic implications

doi:10.3748/wjg.v11.i11.1639

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3957)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

325

HTML

3332

Figures (1-1)

168

Tables (1-1)

132

Sum=3957

Mar 21, 2005 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (111)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Mar 21, 2005; 11(11): 1639-1643
Published online Mar 21, 2005. doi: 10.3748/wjg.v11.i11.1639

Open in New Tab Full Size Figure Download Figure

Figure 1 Overall disease-free survival of CRC patients stratified by IL-6, TNFα and CRP pre-operative serum concentrations. A: Disease-free survival in patients with IL-6<8 pg/mL; B: Disease-free survival in patients with CRP<7 mg/L; C: Disease-free survival in patients with TNFα<5 pg/mL.

Citation: Nikiteas NI, Tzanakis N, Gazouli M, Rallis G, Daniilidis K, Theodoropoulos G, Kostakis A, Peros G. Serum IL-6, TNFα and CRP levels in Greek colorectal cancer patients: Prognostic implications. World J Gastroenterol 2005; 11(11): 1639-1643
URL: https://www.wjgnet.com/1007-9327/full/v11/i11/1639.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i11.1639